Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Anaprime Oph Gel .1 mg Gel is a Health Canada–registered veterinary drug (DIN 00319597) held by Syntex Animal Health, Division Of Syntex Inc., containing Flumethasone. Health Canada lists its status as Cancelled Post Market (status date 22 Aug 2000). Nexara Health has matched 3 registrations of Flumethasone across 1 other regulated market.

Health Canada registration

DIN00319597
Brand nameAnaprime Oph Gel
Active ingredientFlumethasone
Strength.1 mg
Dosage formGel
RouteOphthalmic
CompanySyntex Animal Health, Division Of Syntex Inc.
StatusCancelled Post Market — 22 Aug 2000
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Flumethasone registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesFlumethasoneSymbiotec Pharmalab LimitedPowderFDA NDC
United StatesFlumethasoneIndustrias Qumicas Falcn de Mxico, S.A. de C.V. (DR. REDDY'S MEXICO)PowderFDA NDC
United StatesFlumethasoneFarmabios S.p.A.PowderFDA NDC

See every manufacturer of Flumethasone worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Anaprime Oph Gel (DIN 00319597) marketed in Canada?

No. Health Canada lists DIN 00319597 as Cancelled Post Market as of 22 Aug 2000.

Who holds the Canadian licence for this product?

Syntex Animal Health, Division Of Syntex Inc. is the company of record in the Health Canada Drug Product Database.

Is Flumethasone registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00319597, status date 2000-08-22; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00319597, status date 2000-08-22; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 00319597, status date 2000-08-22; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.